Código QR (código de barras bidimensional)

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer

Abstract The presented study investigated the relevance of mutations in 17 cancer genes and response to neoadjuvant chemotherapy in two clinical cohorts of HER2+ breast cancer. 364 samples from HER2+ tumors of the neoadjuvant studies GeparTrio (no anti-HER2 treatment, n = 71) and GeparSepto (dual HE...

ver descrição completa

Na minha lista:
Principais autores: Marion T. Van Mackelenbergh, Nicole Pfarr, Karsten Weber, Michael Untch, Christine Solbach, Andreas Schneeweiss, Paul Jank, Jens Blohmer, Denise Treue, Sabine Schmatloch, Annika Lehmann, Claus Hanusch, Theresa Link, Christine Sers, Vesna Bjelic-Radisic, Michael Hummel, Jens Huober, Wolfgang D. Schmitt, Peter A. Fasching, Bahriye Aktas, Kerstin Rhiem, Mattea Reinisch, Valentina Nekljudova, Carsten Denkert, Sibylle Loibl
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Portfolio 2026-04-01
coleção:npj Breast Cancer
Acesso em linha:https://doi.org/10.1038/s41523-026-00948-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados